| HOME >> BIOLOGY >> TECHNOLOGY |
Weighted average
common shares
outstanding 11,608,026 11,913,480 11,891,469 11,773,317
Diluted weighted
average common shares
outstanding 11,608,026 11,913,480 12,471,298 12,580,526
CONDENSED CONSOLIDATED BALANCE SHEETS
June 30,
2008 June 30,
(Unaudited) 2007
Assets
Current assets:
Cash, cash equivalents and
investments $63,496,141 $34,331,454
Trade receivables 6,617,156 6,220,727
Other receivables 9,030,699 6,799,369
Inventory 9,270,864 7,392,116
Prepaids and other assets 1,859,958 1,977,592
Deferred tax asset, current 4,277,864 3,151,350
Total current assets 94,552,682 59,872,608
Property, plant and equipment, net 59,598,308 63,821,312
Other non-current assets 8,277,574 16,831,544
Total assets $162,428,564 $140,525,464
Liabilities and stockholders' equity
Current liabilities:
Accounts payable and accrued
expenses $8,972,222 $6,178,026
Current portion of debt 1,399,997 186,667
Deferred revenue 601,131 350,739
Other current liabilities 686,267 -
Total current liabilities 11,659,617 6,715,432
Long term portion of deferred revenue 507,642 611,196
Long term portion of debt 32,783
'/>"/>
| SOURCE Kensey Nash Corporation Copyright©2008 PR Newswire. All rights reserved |